Published in:

01-05-2004

Octagam^® 5%, an Intravenous IgG Product, Is Efficacious and Well Tolerated in Subjects with Primary Immunodeficiency Diseases

Authors: Hans D. Ochs, Paul J. Pinciaro, The Octagam Study Group

Published in: Journal of Clinical Immunology | Issue 3/2004